AMCP Announces a Strategic Partnership with IPD Analytics

Topic(s):

Alexandria, Va., April 7, 2026 — The Academy of Managed Care Pharmacy (AMCP) is pleased to announce a strategic partnership with IPD Analytics. Through the partnership, select AMCP staff will have access to IPD Analytics’ platform and insights, which AMCP will use to inform resources we develop for our members. This collaboration will enhance AMCP’s and its members’ understanding of market dynamics, formulary trends, pharmacy cost considerations, and key market catalysts, supporting a shared goal of informed decision-making across health care stakeholders.  

IPD Analytics is an independent insights provider supporting health care decision-makers with comprehensive drug life-cycle analysis, payer and formulary management guidance, market access intelligence, clinical pipeline tracking, generic and biosimilar entry surveillance, medical benefit pricing and coding solutions, budget impact analysis, sales and rebate forecasting, legislation and regulatory tracking, and more. IPD’s strategic insights enable proactive formulary and pharmacy cost management, with access to clinical pharmacy experts, a wide range of actionable content, and proprietary data and analytics.  

Through this partnership, IPD Analytics continues to support more informed, rational decision-making across the health care industry with its syndicated insights. Serving as a common language for all participants, stakeholders can align around market realities and harmonize expectations. “We’re proud to provide timely, data-driven insights that add visibility to all industry conversations,” said Howard Krass, Founder and CEO of IPD Analytics.

“Partnering with IPD Analytics aligns with our commitment to providing our members with trusted insights that enhance formulary evaluation, pharmacy cost management, and broader health care decision-making. We are excited to work together to deliver resources that reflect real-world market dynamics and support value-driven care,” said Susan Cantrell, MHL, RPh, CAE, CEO of AMCP.

By working together, AMCP and IPD Analytics aim to equip AMCP members and other health care decision‑makers with high-quality, transparent resources and education informed by real-world market insights that complement AMCP’s existing education, research, and professional development initiatives as they navigate an increasingly complex and rapidly evolving marketplace. 

About AMCP

AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse membership of pharmacists, physicians, nurses, biopharmaceutical professionals, and other stakeholders leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management and help patients access cost-effective and safe medications and other drug therapies. AMCP members improve the lives of nearly 300 million Americans served by private and public health plans, pharmacy benefit management firms, and emerging care models. Visit www.amcp.org.   

About IPD Analytics

IPD Analytics brings transparency, efficiency, and clarity to stakeholders across the pharmaceutical landscape by combining proprietary intelligence, advanced analytics, and deep domain expertise. By delivering foresight at speed, transforming dynamic market information into actionable insights, forecasts, and strategic recommendations, IPD has helped health care organizations move from reactive decision-making to proactive, forward-looking strategy for over 20 years. For more information about IPD Analytics, please visit IPD's website or follow IPD Analytics on LinkedIn.   

Related